EL.En. S.p.A. (ELEAF)
OTCMKTS · Delayed Price · Currency is USD
9.48
-7.13 (-42.91%)
Feb 5, 2026, 4:00 PM EST
EL.En. Revenue
EL.En. had revenue of 137.77M EUR in the quarter ending September 30, 2025, with 1.40% growth. This brings the company's revenue in the last twelve months to 580.41M, up 17.28% year-over-year. In the year 2024, EL.En. had annual revenue of 565.85M, down -1.76%.
Revenue (ttm)
580.41M EUR
Revenue Growth
+17.28%
P/S Ratio
1.95
Revenue / Employee
408.74K EUR
Employees
1,420
Market Cap
1.32B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 565.85M | -10.17M | -1.76% |
| Dec 31, 2023 | 576.01M | -97.57M | -14.49% |
| Dec 31, 2022 | 673.58M | 102.18M | 17.88% |
| Dec 31, 2021 | 571.40M | 163.32M | 40.02% |
| Dec 31, 2020 | 408.08M | 7.32M | 1.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
EL.En. News
- 3 months ago - EL.En. S.p.A. (ELEAF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - EL.En. S.p.A. (ELEAF) Q2 2025 Earnings Call Transcript - Seeking Alpha